ID

30227

Description

Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01016379

Lien

https://clinicaltrials.gov/show/NCT01016379

Mots-clés

  1. 22/05/2018 22/05/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

22 mai 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Leukemia NCT01016379

Eligibility Leukemia NCT01016379

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT01016379
Criteria
Description

Criteria

diagnosis of acute lymphoblastic leukemia (all)
Description

Acute lymphocytic leukemia

Type de données

boolean

Alias
UMLS CUI [1]
C0023449
previously enrolled in cog-9900, cog-c1991, cog-aall03b1, cog-aall05b1, cog-aall08p1, or other current cog or legacy trials for all and consented to submit blood and marrow samples for biological research studies
Description

Study Subject Participation Status | Clinical Trial ALL | Blood specimen Submission Consented | Bone marrow specimen Submission Consented

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0008976
UMLS CUI [2,2]
C0023449
UMLS CUI [3,1]
C0178913
UMLS CUI [3,2]
C1515023
UMLS CUI [3,3]
C2711213
UMLS CUI [4,1]
C0438737
UMLS CUI [4,2]
C1515023
UMLS CUI [4,3]
C2711213
meets ≥ 1 of the following criteria:
Description

Criteria Fulfill

Type de données

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1550543
germline dna that has been extracted from blood (preferentially) or bone marrow (if no appropriate blood available) that was collected on or after day 28 of remission indication therapy, or is known to come from a sample that contained < 10% leukemic blasts
Description

Germline DNA Blood | Germline DNA Bone Marrow | Remission Indication Therapy | Leukemic Blast Count

Type de données

boolean

Alias
UMLS CUI [1,1]
C2986526
UMLS CUI [1,2]
C0005767
UMLS CUI [2,1]
C2986526
UMLS CUI [2,2]
C0005953
UMLS CUI [3,1]
C0544452
UMLS CUI [3,2]
C3146298
UMLS CUI [3,3]
C0087111
UMLS CUI [4]
C2697913
all blast dna that has been extracted from bone marrow (preferentially) or blood (if from a sample that contained > 90% leukemic blasts and no diagnostic bone marrow is available) that was collected at the time of all diagnosis
Description

ALL Blast DNA Bone Marrow | ALL Blast DNA Blood | Leukemic Blast Count

Type de données

boolean

Alias
UMLS CUI [1,1]
C0023449
UMLS CUI [1,2]
C0368761
UMLS CUI [1,3]
C0012854
UMLS CUI [1,4]
C0005953
UMLS CUI [2,1]
C0023449
UMLS CUI [2,2]
C0368761
UMLS CUI [2,3]
C0012854
UMLS CUI [2,4]
C0005767
UMLS CUI [3]
C2697913
patient characteristics:
Description

Client Characteristics

Type de données

boolean

Alias
UMLS CUI [1]
C0815172
not specified
Description

Unspecified

Type de données

boolean

Alias
UMLS CUI [1]
C0205370
prior concurrent therapy:
Description

Therapeutic procedure

Type de données

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Description

ID.9

Type de données

boolean

Similar models

Eligibility Leukemia NCT01016379

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT01016379
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Acute lymphocytic leukemia
Item
diagnosis of acute lymphoblastic leukemia (all)
boolean
C0023449 (UMLS CUI [1])
Study Subject Participation Status | Clinical Trial ALL | Blood specimen Submission Consented | Bone marrow specimen Submission Consented
Item
previously enrolled in cog-9900, cog-c1991, cog-aall03b1, cog-aall05b1, cog-aall08p1, or other current cog or legacy trials for all and consented to submit blood and marrow samples for biological research studies
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2,1])
C0023449 (UMLS CUI [2,2])
C0178913 (UMLS CUI [3,1])
C1515023 (UMLS CUI [3,2])
C2711213 (UMLS CUI [3,3])
C0438737 (UMLS CUI [4,1])
C1515023 (UMLS CUI [4,2])
C2711213 (UMLS CUI [4,3])
Criteria Fulfill
Item
meets ≥ 1 of the following criteria:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Germline DNA Blood | Germline DNA Bone Marrow | Remission Indication Therapy | Leukemic Blast Count
Item
germline dna that has been extracted from blood (preferentially) or bone marrow (if no appropriate blood available) that was collected on or after day 28 of remission indication therapy, or is known to come from a sample that contained < 10% leukemic blasts
boolean
C2986526 (UMLS CUI [1,1])
C0005767 (UMLS CUI [1,2])
C2986526 (UMLS CUI [2,1])
C0005953 (UMLS CUI [2,2])
C0544452 (UMLS CUI [3,1])
C3146298 (UMLS CUI [3,2])
C0087111 (UMLS CUI [3,3])
C2697913 (UMLS CUI [4])
ALL Blast DNA Bone Marrow | ALL Blast DNA Blood | Leukemic Blast Count
Item
all blast dna that has been extracted from bone marrow (preferentially) or blood (if from a sample that contained > 90% leukemic blasts and no diagnostic bone marrow is available) that was collected at the time of all diagnosis
boolean
C0023449 (UMLS CUI [1,1])
C0368761 (UMLS CUI [1,2])
C0012854 (UMLS CUI [1,3])
C0005953 (UMLS CUI [1,4])
C0023449 (UMLS CUI [2,1])
C0368761 (UMLS CUI [2,2])
C0012854 (UMLS CUI [2,3])
C0005767 (UMLS CUI [2,4])
C2697913 (UMLS CUI [3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.9
Item
see disease characteristics
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial